Vertex Pharmaceuticals Inc. (VRTX)

Index: Nasdaq 100
0.75%
$0.88
$118.30
02:16 29/04/17
$118.30
02:16 29/04/17
DAILY VARIATION
0.75%
$0.88
VOLUME
3,387,189
DATA
52 Week High
$118.30
52 Week Low
$72.02
Shares Issued
249.04m
Market Cap
$29,461.80m
RiskGrade
217
Beta
1.64
MENU

Vertex Pharmaceuticals Inc. Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -45.2% 5.3%
ROCE 0.0%
Latest F'cast
P/E -51.2 7,248.4
PEG 0.0 0.9
Pr/Revenue 28.5 14.7
Pr/Book 26.9
Latest F'cast
Revenue 77.9% -31.7%
PBT 0.0% n/a
EPS 0.0% -65.8%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 1,527.04 -12.38 -50.00¢ -83.8 0.0 n/a n/a 0.0%
2013-12-31 1,211.97 -626.04 -198.00¢ -37.5 0.0 n/a n/a 0.0%
2014-12-31 580.41 -734.88 -314.00¢ -37.8 0.0 n/a n/a 0.0%
2015-12-31 1,032.34 -557.80 -231.00¢ -54.5 0.0 n/a n/a 0.0%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2016-12-31 1,702.17 -68.29 85.00c 13,729.4 n/a 0% 0.00c 0.0%
2017-12-31 1,999.31 106.73 159.13c 7,248.4 83.1 87% 0.00c 0.0%
2018-12-31 2,582.13 572.32 296.52c 3,890.0 45.1 86% 0.00c 0.0%

Regulatory News

No results found

Newspaper Links

No results found